DMAAU
Drugs Made In America Acquisition Corp. UnitsNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$308.64M
P/E Ratio
—
EPS
—
Beta
—
52W High
$12.50
52W Low
$10.30
50-Day MA
$10.77
200-Day MA
$10.57
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Drugs Made In America Acquisition Corp. Units
Drugs Made In America Acquisition Corp. Units (DMAAU) is a special purpose acquisition company (SPAC) dedicated to merging with pioneering firms in the pharmaceutical and healthcare industries. Backed by a seasoned management team with extensive industry expertise, DMAAU aims to capitalize on the growing shift towards domestic drug production and innovative healthcare solutions. As the U.S. healthcare landscape increasingly prioritizes affordability and accessibility, DMAAU presents institutional investors with a compelling opportunity to participate in the future of healthcare transformation.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.46% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.22 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 18.80% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $29.17M |
| Float | $27.90M |
| % Insiders | 17.88% |
| % Institutions | 1.54% |
Historical Volatility
HV 10-Day
5.18%
HV 20-Day
23.47%
HV 30-Day
28.75%
HV 60-Day
21.08%
HV Rank
95.2%
Volatility is currently contracting
More FINANCIAL SERVICES Stocks
Data last updated: 7/9/2026